A carregar...
Aspirin for everyone older than 50?: AGAINST
Current population screening for vascular disease is neither efficient nor effective. Peter Elwood and colleagues believe we should have a public information strategy highlighting the benefits (and risks) of aspirin for older people, but Colin Baigent argues that the evidence of benefit is not yet s...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group Ltd.
2005
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC558386/ https://ncbi.nlm.nih.gov/pubmed/15961819 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|